Immunotoxicity of Perfluorinated Compounds: Recent Developments

Perfluorinated compounds (PFCs) are environmentally widespread, persistent, and bioaccumulative chemicals with multiple toxicities reported in experimental models and wildlife, including immunomodulation. The two most commonly detected compounds, which also generally occur in the highest concentrations in environmentally exposed organisms, are perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). PFOA and PFOS have been reported to alter inflammatory responses, production of cytokines, and adaptive and innate immune responses in rodent models, avian models, reptilian models, and mammalian and nonmammalian wildlife. Mounting evidence suggests that immune effects in laboratory animal models occur at serum concentrations below, within the reported range, or just above those reported for highly exposed humans and wildlife. Thus, the risk of immune effects for humans and wildlife exposed to PFCs cannot be discounted, especially when bioaccumulation and exposure to multiple PFCs are considered. This review contains brief descriptions of current and recently published work exploring immunomodulation by PFOA, PFOS, and other PFCs in rodent models, alternative laboratory models, and wildlife.

[1]  Paul D. Jones,et al.  Accumulation of perfluorooctane sulfonate in marine mammals. , 2001, Environmental science & technology.

[2]  Yi-he Jin,et al.  Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice , 2011, Archives of Toxicology.

[3]  Jeffrey H Mandel,et al.  Epidemiologic Assessment of Worker Serum Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) Concentrations and Medical Surveillance Examinations , 2003, Journal of occupational and environmental medicine.

[4]  G. Jiang,et al.  Modulation of dietary fat on the toxicological effects in thymus and spleen in BALB/c mice exposed to perfluorooctane sulfonate. , 2011, Toxicology letters.

[5]  A. Calafat,et al.  Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. , 2004, Environmental science & technology.

[6]  Mark J. Strynar,et al.  Perfluorooctanoic Acid–Induced Immunomodulation in Adult C57BL/6J or C57BL/6N Female Mice , 2008, Environmental health perspectives.

[7]  Yi-he Jin,et al.  Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice , 2009, Archives of Toxicology.

[8]  Marina Marinovich,et al.  In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs). , 2011, Toxicology and applied pharmacology.

[9]  Qian Yang,et al.  Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. , 2002, International immunopharmacology.

[10]  J. M. Keller,et al.  Temporal and spatial trends of perfluorinated compounds in juvenile loggerhead sea turtles (Caretta caretta) along the East Coast of the United States. , 2010, Environmental science & technology.

[11]  J. Depierre,et al.  High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. , 2009, Toxicology.

[12]  N Yamashita,et al.  Perfluorinated compounds in some terrestrial and aquatic wildlife species from Poland , 2007, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.

[13]  C. Glass,et al.  WY14,643, a PPARα Ligand, Has Profound Effects on Immune Responses In Vivo1 , 2002, The Journal of Immunology.

[14]  Thomas Griesbacher,et al.  Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis. , 2008, International immunopharmacology.

[15]  Melvin E Andersen,et al.  Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  M. Peden‐Adams,et al.  Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice , 2011, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.

[17]  R. Luebke,et al.  Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  Nobuyoshi Yamashita,et al.  Fluorinated alkyl compounds including long chain carboxylic acids in wild bird livers from Japan. , 2011, Chemosphere.

[19]  C. Lau,et al.  Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse. , 2009, Reproductive toxicology.

[20]  Kurunthachalam Kannan,et al.  Association between perfluorinated compounds and pathological conditions in southern sea otters. , 2006, Environmental science & technology.

[21]  F. Burleson,et al.  Testing Human Biologicals in Animal Host Resistance Models , 2008, Journal of immunotoxicology.

[22]  Steve E. Calvano,et al.  Acute Inflammatory Response to Endotoxin in Mice and Humans , 2005, Clinical Diagnostic Laboratory Immunology.

[23]  L. Luttrell,et al.  Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. , 2007, Molecular immunology.

[24]  C. Wilson,et al.  Cutting edge: CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigens. , 1999, Journal of immunology.

[25]  J. Depierre,et al.  Effects of peroxisome proliferators on the thymus and spleen of mice , 2000, Clinical and experimental immunology.

[26]  J. M. Keller,et al.  Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  Kyle Steenland,et al.  Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. , 2009, American journal of epidemiology.

[28]  H. Haase,et al.  Impact of perfluorooctanesulfonate and perfluorooctanoic acid on human peripheral leukocytes. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[29]  G. Bossard Marine Mammals as Sentinel Species for Oceans and Human Health , 2006 .

[30]  M. A. Mohd,et al.  Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. , 2004, Environmental science & technology.

[31]  D. Keil,et al.  Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice , 2011, Journal of immunotoxicology.

[32]  Shinsuke Tanabe,et al.  Perfluorooctanesulfonate and related fluorochemicals in albatrosses, elephant seals, penguins, and polar skuas from the Southern Ocean. , 2006, Environmental science & technology.

[33]  S. Hopkins Central nervous system recognition of peripheral inflammation: a neural, hormonal collaboration. , 2007, Acta bio-medica : Atenei Parmensis.

[34]  T. Scott,et al.  Developmental toxicity in white leghorn chickens following in ovo exposure to perfluorooctane sulfonate (PFOS). , 2009, Reproductive toxicology.

[35]  J. M. Keller,et al.  Effects of Organochlorine Contaminants on Loggerhead Sea Turtle Immunity: Comparison of a Correlative Field Study and In Vitro Exposure Experiments , 2005, Environmental health perspectives.

[36]  R. Blust,et al.  Evaluation of the toxicological effects of perfluorooctane sulfonic acid in the common carp (Cyprinus carpio). , 2003, Aquatic toxicology.

[37]  C. Vinson,et al.  CD40-Mediated Transcriptional Regulation of the IL-6 Gene in B Lymphocytes: Involvement of NF-κB, AP-1, and C/EBP1 , 2003, The Journal of Immunology.

[38]  R. Mehta,et al.  Immunomodulatory Effects of Dietary Potassium Perfluorooctane Sulfonate (PFOS) Exposure in Adult Sprague-Dawley Rats , 2008, Journal of toxicology and environmental health. Part A.

[39]  John P Giesy,et al.  Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the Baltic and the Mediterranean Seas. , 2002, Environmental science & technology.

[40]  Sang-Hyun Kim,et al.  Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice , 2009, Environmental toxicology.

[41]  Derek C G Muir,et al.  Polyfluoroalkyl compounds in free-ranging bottlenose dolphins (Tursiops truncatus) from the Gulf of Mexico and the Atlantic Ocean. , 2005, Environmental science & technology.

[42]  G. Charnley,et al.  A Margin-of-Exposure Approach to Assessment of Noncancer Risks of Dioxins Based on Human Exposure and Response Data , 2008, Environmental health perspectives.

[43]  D. Keil,et al.  Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  R. Clark The role of PPARs in inflammation and immunity , 2002, Journal of leukocyte biology.

[45]  Ronny Blust,et al.  High accumulation of perfluorooctane sulfonate (PFOS) in marine tucuxi dolphins (Sotalia guianensis) from the Brazilian coast. , 2008, Environmental science & technology.

[46]  L. Birnbaumer,et al.  Differential regulation of lipopolysaccharide and Gram-positive bacteria induced cytokine and chemokine production in splenocytes by Gαi proteins , 2006 .

[47]  John P Giesy,et al.  Perfluorooctanesulfonate and related fluorinated hydrocarbons in mink and river otters from the United States. , 2002, Environmental science & technology.

[48]  J. Moreau,et al.  Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients , 2003, Immunology.

[49]  Nobuyoshi Yamashita,et al.  A survey of perfluorooctane sulfonate and related perfluorinated organic compounds in water, fish, birds, and humans from Japan. , 2003, Environmental science & technology.

[50]  T. Fletcher,et al.  The effect of prenatal perfluorinated chemicals exposures on pediatric atopy. , 2011, Environmental research.

[51]  R. Luebke,et al.  Immunotoxicity of Perfluorooctanoic Acid and Perfluorooctane Sulfonate and the Role of Peroxisome Proliferator-Activated Receptor Alpha , 2009, Critical reviews in toxicology.

[52]  S. Anderson,et al.  Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[53]  Qiang Yang,et al.  Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. , 2001, Biochemical pharmacology.

[54]  Yi-he Jin,et al.  Subchronic effects of perfluorooctanesulfonate exposure on inflammation in adult male C57BL/6 mice , 2012, Environmental toxicology.

[55]  D. Consonni,et al.  Thirty Years of Medical Surveillance in Perfluooctanoic Acid Production Workers , 2009, Journal of occupational and environmental medicine.

[56]  K. Andolsek,et al.  Risk assessment , 2003, Nature.

[57]  C. Gennings,et al.  Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[58]  B. Taylor,et al.  Peroxisome Proliferator-Activated Receptor Agonists Inhibit Inflammatory Edema and Hyperalgesia , 2002, Inflammation.

[59]  Yong Zhao,et al.  Immunotoxic effects of perfluorononanoic acid on BALB/c mice. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[60]  J. M. Keller,et al.  Perfluorinated compounds in the plasma of loggerhead and Kemp's ridley sea turtles from the southeastern coast of the United States. , 2005, Environmental science & technology.

[61]  J. Giesy,et al.  Perfluorinated Compounds in Aquatic Organisms at Various Trophic Levels in a Great Lakes Food Chain , 2005, Archives of environmental contamination and toxicology.

[62]  Frank J. Gonzalez,et al.  Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1* , 1999, The Journal of Biological Chemistry.

[63]  K. Lowe,et al.  Lymphoid tissue responses to emulsified perfluorochemicals: comparative aspects. , 1988, Biomaterials, artificial cells, and artificial organs.

[64]  D. Savitz,et al.  Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA) , 2010, Environmental health perspectives.

[65]  Kurunthachalam Kannan,et al.  Perfluorinated contaminants in sediments and aquatic organisms collected from shallow water and tidal flat areas of the Ariake Sea, Japan: environmental fate of perfluorooctane sulfonate in aquatic ecosystems. , 2006, Environmental science & technology.

[66]  R. Dietz,et al.  Preliminary screening of perfluorooctane sulfonate (PFOS) and other fluorochemicals in fish, birds and marine mammals from Greenland and the Faroe Islands. , 2005, Environmental pollution.

[67]  C. Lau,et al.  Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[68]  D. Keil,et al.  Suppression of Humoral Immunity Following Exposure to the Perfluorinated Insecticide Sulfluramid , 2007, Journal of toxicology and environmental health. Part A.

[69]  S. Biswal,et al.  Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886 , 2001 .

[70]  R. Luebke,et al.  Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. , 2009, Critical reviews in toxicology.

[71]  K. Kannan,et al.  Perfluorinated compounds in minke whales (Balaenoptera acutorostrata) and long-beaked common dolphins (Delphinus capensis) from Korean coastal waters. , 2010, Marine pollution bulletin.

[72]  J. DeWitt,et al.  Are developmentally exposed C57BL/6 mice insensitive to suppression of TDAR by PFOA? , 2010, Journal of immunotoxicology.

[73]  B. Taylor,et al.  Central administration of perfluorooctanoic acid inhibits cutaneous inflammation , 2005, Inflammation Research.

[74]  T. Pineau,et al.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.

[75]  L. Shaw,et al.  Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health Parameters , 2006, Journal of occupational and environmental medicine.

[76]  P. Keipert,et al.  Randomized Safety Studies of Intravenous Perflubron Emulsion. II. Effects on Immune Function in Healthy Volunteers , 2000 .

[77]  Yi-he Jin,et al.  Type 1 and Type 2 cytokines imbalance in adult male C57BL/6 mice following a 7-day oral exposure to perfluorooctanesulfonate (PFOS) , 2011, Journal of immunotoxicology.

[78]  Marcel Eens,et al.  PFOS levels in the blood and liver of a small insectivorous songbird near a fluorochemical plant. , 2007, Environment international.

[79]  Jeffrey H Mandel,et al.  Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. , 2003, Environmental health perspectives.

[80]  Yi-he Jin,et al.  Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice , 2009, Archives of Toxicology.

[81]  Scott A Mabury,et al.  Identification of long-chain perfluorinated acids in biota from the Canadian Arctic. , 2004, Environmental science & technology.

[82]  Yimin,et al.  A Regulatory Effect of the Balance between TNF-α and IL-6 in the Granulomatous and Inflammatory Response to Rhodococcus aurantiacus Infection in Mice1 , 2006, The Journal of Immunology.

[83]  Jiayin Dai,et al.  Alterations of cytokines and MAPK signaling pathways are related to the immunotoxic effect of perfluorononanoic acid. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[84]  J. Depierre,et al.  The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha). , 2009, Toxicology.

[85]  J. M. Keller,et al.  Health effects of perfluorinated compounds—What are the wildlife telling us? , 2009 .

[86]  N. Yamashita,et al.  Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice. , 2009, The Journal of toxicological sciences.

[87]  John W. Froehlich,et al.  Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.

[88]  B. Spiess The Physiology and Pathophysiology of the Hyperbaric and Diving Environments Perfluorocarbon emulsions as a promising technology : a review of tissue and vascular gas dynamics , 2009 .

[89]  C. Lau,et al.  Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[90]  J. M. Keller,et al.  Immunotoxicology and Implications for Reptilian Health , 2005 .

[91]  D. H. Ramdhan,et al.  Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor alpha, but not human PPARalpha. , 2009, Toxicology.

[92]  P. Keipert,et al.  Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers. , 2000, Anesthesia and analgesia.

[93]  J. Gimble,et al.  Effect of Peroxisome Proliferator-Activated Receptor Alpha Activators on Tumor Necrosis Factor Expression in Mice during Endotoxemia , 1999, Infection and Immunity.

[94]  G. Bishop,et al.  The CD40-CD154 interaction in B cell-T cell liaisons. , 2003, Cytokine & growth factor reviews.

[95]  J. Giesy,et al.  Global distribution of perfluorooctane sulfonate in wildlife. , 2001, Environmental science & technology.